Skip to content

A study comparing two laser light treatment methods for treating white patches on cheeks and gums in the mouth

Evaluation of treatment outcomes of Er:YAG and Diode Lasers in the management of oral leukoplakia - A randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113637
Enrollment
22
Registered
2026-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K132- Leukoplakia and other disturbancesof oral epithelium, including tongue

Interventions

Intervention1: Er:YAG laser Group: Er:YAG laser using 2940nm with h2o handpiece operated in MSP Mode at a frequency of 10Hz and an energy setting of 120mj with Air/Water ratio 2/2 will be focussed on

Sponsors

Dr Jyothi Chunduri
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 years and above. 2. Clinically and histologically confirmed cases of oral leukoplakia. 3. Patients willing to undergo follow-up for a minimum of 6 months. 4. Both homogeneous and non-homogeneous leukoplakia with or without dysplasia. 5. Patient willing to quit the habit

Exclusion criteria

Exclusion criteria: 1.Histopathologically confirmed malignant transformation or carcinoma. 2.Patients who are not willing to participate, follow-up and quit the habit.

Design outcomes

Primary

MeasureTime frame
Postoperative pain using VAS score Postoperative bleedingTimepoint: Postoperative pain using VAS score - 1 week. Postoperative bleeding - 1, 3 days

Secondary

MeasureTime frame
Wound healing using landry index Recurrence rateTimepoint: 3rd day 7th day 14th day recurrence-8 months

Countries

India

Contacts

Public ContactDr K Jyothirmai

Vishnu Dental College

jyothirmaik@vdc.edu.in9866432477

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026